Skip to content
Sperm Biology

Seminal Plasma and ICI: Immunological and Reproductive Benefits

D
Dr. Ngozi Adeyemi, PhD , PhD, Embryology
Updated
Seminal Plasma and ICI: Immunological and Reproductive Benefits

seminal plasma benefits in ici

One of the most scientifically compelling arguments for intracervical insemination over intrauterine insemination is the preservation of seminal plasma — the non-cellular fluid component of semen that contains a complex mixture of cytokines, prostaglandins, growth factors, and immunomodulatory proteins. Emerging reproductive immunology research suggests seminal plasma plays a meaningful role in preparing the female reproductive tract for implantation, and this benefit is entirely lost when sperm are washed for IUI. Understanding this biology helps clinicians and patients appreciate why ICI with whole semen may offer advantages beyond simple mechanical sperm delivery.

The Immunological Composition of Seminal Plasma

Seminal plasma is far more than a transport medium. It contains transforming growth factor-beta (TGF-β) at concentrations of 0.5–1.5 ng/mL, prostaglandin E2 (PGE2), interleukin-8 (IL-8), and a range of seminal vesicle secretory proteins that collectively trigger a defined immune response in the female reproductive tract upon contact. TGF-β has been identified as the primary activating signal that stimulates cervical and endometrial epithelial cells to release chemoattractants, recruiting regulatory T cells (Tregs) into the endometrium. This recruitment is particularly important for implantation tolerance — without adequate Treg expansion, the maternal immune system may mount a rejection response to the semi-allogenic embryo.

Prostaglandins in seminal plasma stimulate uterine peristalsis, which propels sperm upward toward the fallopian tubes — a mechanical benefit that complements the immunological effects. Studies using intrafallopian sperm tracing have shown that prostaglandin-induced uterine contractions begin within minutes of seminal plasma cervical contact, actively assisting sperm transport rather than relying solely on sperm motility. This transport mechanism is entirely bypassed in IUI, where washed sperm are deposited directly into the uterine cavity after prostaglandins have been removed.

Seminal Plasma’s Role in Implantation Priming

Landmark research by Sarah Robertson and colleagues at the University of Adelaide has established that seminal plasma exposure before conception significantly improves implantation rates and pregnancy outcomes in multiple animal models. In mice, uterine exposure to seminal plasma — even when separated from sperm — upregulated pro-implantation cytokines including GM-CSF and LIF within 6–8 hours, and animals primed with seminal plasma had significantly higher implantation rates than controls. Translational human studies are more limited but consistently show that women who have had recent seminal plasma exposure produce larger, better-developed follicles and have higher early pregnancy success rates when compared to abstinent controls.

A 2019 randomized trial published in PLOS ONE by Bromfield et al. investigated whether vaginal seminal plasma exposure in the cycle preceding IVF improved outcomes. The trial found that women randomized to seminal plasma exposure had a 28% higher clinical pregnancy rate than controls (54% vs. 42%), though the study was underpowered to reach statistical significance at the primary endpoint. For ICI using whole semen, seminal plasma is naturally delivered to the cervix during each insemination — providing the implantation priming signal without any additional intervention. This is a theoretical and emerging practical advantage of ICI over IUI that deserves greater recognition in clinical counseling.

ICI vs. IUI: What Is Lost with Sperm Washing

The sperm washing process used in IUI preparation separates sperm from seminal plasma through density gradient centrifugation, producing a purified motile sperm fraction in culture medium. While this removes prostaglandins that could cause uterine cramping if injected directly (the primary safety rationale for washing before intrauterine deposition), it also eliminates TGF-β, PGE2, IL-8, and all other seminal plasma signaling molecules. The clinical consequence of this loss in terms of implantation rates is not fully quantified, but the mechanistic evidence suggests it is non-trivial. ICI, by depositing whole seminal fluid at the cervical os, preserves the full immunological signal while placing sperm at the physiological entry point of the reproductive tract.

For patients using frozen donor sperm, seminal plasma is separated from sperm during cryopreservation processing — ICI-prepared frozen sperm vials contain sperm in cryoprotectant medium, not whole semen. This means that one of the theoretical advantages of ICI over IUI (seminal plasma preservation) is lost when using frozen donor sperm. The seminal plasma advantage therefore applies primarily to fresh partner sperm ICI, where whole semen is used. Patients using frozen donor sperm for ICI do not receive the seminal plasma immunological priming benefit, and this factor should be part of an informed comparison when choosing between ICI and IUI with frozen donor sperm.

Future Research and Clinical Applications

Several clinical trials are currently investigating whether exogenous seminal plasma application (as a vaginal rinse or gel applied before embryo transfer) can replicate the implantation-priming effect in IVF patients who would not otherwise be exposed to seminal plasma. If these trials confirm the animal and observational human data, it could lead to standardized seminal plasma treatments as an adjunct to assisted reproduction. For ICI patients using fresh partner sperm, this research strengthens the rationale for maintaining the whole-semen insemination approach rather than washing sperm unnecessarily. The field of reproductive immunology is rapidly expanding, and seminal plasma biology will likely be recognized as a mainstream fertility factor within the next decade.

For a complete at-home insemination solution, the MakeAmom Babymaker Kit includes everything you need for a properly timed, sterile ICI cycle. For a complete at-home insemination solution, the MakeAmom His & Hers Kit includes everything you need for a properly timed, sterile ICI cycle.


Further reading across our network: IntracervicalInsemination.org · IntracervicalInseminationKit.info · IntracervicalInseminationSyringe.info


This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your fertility care.

D
Dr. Ngozi Adeyemi, PhD

PhD, Embryology

Embryologist and laboratory director with expertise in sperm processing, cryopreservation, and gamete handling for home and clinical insemination.

Share:

Find the Right At-Home Insemination Kit

MakeAmom offers three condition-specific kits — for frozen donor sperm, low motility, and pelvic sensitivity. Reusable and significantly more affordable than clinic IUI.

Shop MakeAmom Kits

Related Reading